Monday November 23 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Biovest International

Biovest International Inc, is a majority-owned subsidiary of Accentia Biopharmaceuticals Inc., a vertically-integrated specialty biopharmaceutical company with services to commercialize targeted therapeutics. Accentia is a publicly traded company (NASDAQ: ABPI) that has a product portfolio featuring targeted therapeutics, specialty sales and marketing, pharmacoeconomic services, product development, and specialty distribution. Biovest has a deep foundation in the manufacture of biological drugs from small research scale quantities to large volumes for Phase I and Phase II clinical material. In addition, Biovest International develops, manufactures, and markets patented cell culture systems and equipment to pharmaceutical, diagnostic and biotechnology companies, as well as leading research institutions worldwide. For over 10 years the company has operated the National Cell Culture Center (NCCC) under a grant from the National Institutes of Health.


Contact Details:
Biotech Building 4 377 Plantation Street
Worcester
01605
United States of America
Tel:508-793-0001
Fax:508-798-0899
Email:ncccinfo@nccc.com
WWW:

www.biovest.com/




Recent Publications by Biovest International:

Use of hollow fiber systems for rapid and direct scale up of antibody production from hybridoma cell lines cultured in CL-1000 flasks using BD Cell MAb medium.
The combination of BD Cell MAb medium with the CL-1000 flask is...
13th November, 2008
BioVest International, Inc., 8500 Evergreen Boulevard, Minneapolis, MN, Cytotechnology. 2003 Sep;42(3):155-62.
DOI Direct Link
Optimal NS0 cell growth in a hollow fiber bioreactor requires increased serum concentration or a cholesterol supplement on the cell side of the fiber.
An NSO/GS cell line secreting a humanized antibody was routinely...
10th August, 2004
BioVest International, Inc., 8500 Evergreen Boulevard, Minneapolis, Biotechnol Prog. 2003 Nov-Dec;19(6):1762-6.
DOI Direct Link
Antibody production by a hybridoma cell line at high cell density is limited by two independent mechanisms.
Our previous attempt to model the stationary phase of production-scale...
18th January, 2003
Biovest International, Inc., 8500 Evergreen Boulevard, Minneapolis, Biotechnol Bioeng. 2002 Aug 5;79(3):277-83.
DOI Direct Link

Press Releases on Biovest International:

BioPortfolio Logo
Reportlinker Adds Global In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2015 18th November, 2009 Reportlinker
NEW YORK, Nov. 18 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue. Global In Vitro Diagnostics Investment Opportunities, Analysis and

BioNews Results for Biovest International:

CI Index of cancer immunotherapy stocks increases 80% during quarter; two companies lead CI index
News-Medical.Net:  Oct 21 2009 10:22AM Matching: biovest international
Mentor Capital Cancer Immunotherapy Index Improves at a 320% Annualized Rate for Quarter
SmartBrief:  Oct 21 2009 4:51AM Matching: biovest international
Mentor Capital Cancer Immunotherapy Index Improves at a 320% Annualized Rate for Quarter
Genetic Engineering News:  Oct 20 2009 8:21PM Matching: biovest international
Mentor Capital Cancer Immunotherapy Index Improves at a 320% Annualized Rate for Quarter
Yahoo! Canada:  Oct 20 2009 7:21PM Matching: biovest international
Mentor Capital Cancer Immunotherapy Index Improves at a 320% Annualized Rate for Quarter
Earthtimes.org:  Oct 20 2009 7:13PM Matching: biovest international
Promote your company here: BioNewsCast - Press Release Distribution

View more Biovest International news.

Biovest International Clinical Trials:

Study of the BiovaxId Tumor Derived Idiotype Vaccine in Patients With Follicular Lymphoma

Biovest International (BVTI.OB) Financial information Links from Barchart

BVTI.OB Quote from from Barchart.com
BVTI.OB Chart from from Barchart.com
BVTI.OB Profile from from Barchart.com
BVTI.OB Opinion from from Barchart.com

View more Biovest International finance information.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 369 times since April 2007, the link to the organisation's website has been followed 46 times

Search for more companies in Worcester

Search for more companies in



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Biovest International

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.